We serve N,N’-Bis(9-Fluorenylmethyloxycarbonyl)-L-Histidine CAS:98929-98-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: N,N'-Bis(9-Fluorenylmethyloxycarbonyl)-L-Histidine
CAS.NO: 98929-98-7
Molecular Formula: C36H29N3O6
Molecular Weight: 599.63200
Synonyms:
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-(9H-fluoren-9-ylmethoxycarbonyl)imidazol-4-yl]propanoic acid
Physical and Chemical Properties:
Density: 1.38g/cm3
Boiling point: /
Melting point: 144-155ºC
Flash point:/
Refractive index: 1.696
Specification:
Appearance: White powder
Purity:≥98%
Loss on drying:≤0.5%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at -15ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.
Contact us for information like N,N’-Bis(9-Fluorenylmethyloxycarbonyl)-L-Histidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-(9H-fluoren-9-ylmethoxycarbonyl)imidazol-4-yl]propanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,N’-Bis(9-Fluorenylmethyloxycarbonyl)-L-Histidine Use and application,(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-(9H-fluoren-9-ylmethoxycarbonyl)imidazol-4-yl]propanoic acid technical grade,usp/ep/jp grade.
Related News: International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.3-Chloro-1-phenylpropan-1-ol manufacturer Physiologically relevant interactions with test molecules or protein ligands can be identified with high sensitivity and specificity.3-bromo-1-phenyl-5-pyridin-2-ylpyridin-2-one supplier “We are very worried,” Chuang Shuk-kwan, a health official, said at a news conference on Sunday. “Everyone should prepare mentally for the possibility that the disease is spreading within the community.”trimethyl(1,2,4-triazol-1-yl)silane vendor After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing.This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.
